On the upside
NeuroMetrix (Nasdaq: NURO) completed its private placement of approximately $18.7 million in stocks and warrants.
The European Patent Office granted CytRx (Nasdaq: CYTR) a patent for its arimoclomol treatment for neurodegenerative diseases of the central nervous system.
Shares of Motorola (NYSE: MOT) surged in anticipation of a collaboration with Google (Nasdaq: GOOG) to develop a new mobile phone.
On the downside
Fourth quarter earnings tumbled for Aceto (Nasdaq: ACET) as revenue dropped.
E-Trade (Nasdaq: ETFC) announced the retirement of chairman and chief executive Don Layton at the end of this year.
Wells Fargo (NYSE: WFC) announced an internal investigation into allegations that an employee improperly used bank owned property in Malibu, California.
In the broad market, advancing issues outpaced decliners by a margin of 9 to 7 on the NYSE while decliners edged out advancers by more than 7 to 5 on Nasdaq. The Russell 2000 which tracks small cap stocks eased a point to 593.
